Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: opioid

What You Need to Know About a Proposed Risk Evaluation and Mitigation Strategy Program for Opioid Analgesics

Staff  |  March 1, 2013

The U.S. Food and Drug Administration favors enacting a mandatory opioid-prescribing training program for dispensers of the extended-release and long-acting analgesics

Filed under:From the College Tagged with:Drugseducation and trainingFDAopioid

Legal Updates: As Opioids for Pain Treatment Come Under Greater Scrutiny, Controlled Substance Agreements Matter More

Steven M. Harris, Esq.  |  March 1, 2013

These contracts can communicate a physician’s expectations for a pain treatment plan and guidelines for safe use by their patients

Filed under:Legal UpdatesPractice Support Tagged with:LegalopioidPainpatient communication

Opioids More Dangerous than other Analgesics for Elderly

Sue Pondrom  |  April 13, 2011

Safety events vary among different opioids

Filed under:AnalgesicsDrug UpdatesResearch Rheum Tagged with:NSAIDsOpioidsPainResearchSafetySteroids

Editor's Pick

Cannabis for Pain Management in Rheumatology

Joanna Zeiger, PhD, & Kaleb Michaud, PhD  |  March 7, 2025

‘Cannabis has a long history of being used for pain management,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘What does it mean for rheumatology patients moving forward? Read our article for one answer to this question.’ As cannabis becomes more widely legalized, both in the U.S. and internationally, its use for pain…

Filed under:ConditionsDrug UpdatesPain SyndromesPatient Perspective Tagged with:Editor's PickJoanna ZeigerKaleb MichaudPhD

The 5 Ms: A Simple Framework to Care for Older Patients

Samantha C. Shapiro, MD  |  December 5, 2024

WASHINGTON, D.C.—For the first time in U.S. history, older adults are projected to outnumber children by 2034, and their care poses unique challenges to the rheumatologist.1 Normal physiologic changes of aging include but aren’t limited to falling renal function, changes in pharmacokinetics and bone density loss. At the ACR Convergence 2024 Review Course, Namrata Singh,…

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024elder care

Sunrise, Sunset: A Look Back on the Year in Rheumatology

Jason Liebowitz, MD, FACR  |  December 4, 2024

At the ACR Convergence 2024 Year in Review lecture, experts discussed advancements in disease understanding and treatments, as well as in basic science.

Filed under:ACR ConvergenceConditionsGout and Crystalline ArthritisGuidanceMeeting ReportsOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 goutACR Convergence 2024 RAcardiovascularGoutKnee Osteoarthritis (OA)osteoarthritis (OA)preventionRheumatoid Arthritis (RA)

The Risk of Cardiovascular Events in Patients with RA & More Explored in 3rd Plenary Session

Samantha C. Shapiro, MD  |  January 19, 2024

SAN DIEGO—In one presentation at Plenary Session 3, ACR Convergence 2023, Beth Wallace, MD, MSc, a staff physician at the VA Ann Arbor Healthcare System, Michigan, and an assistant professor at the University of Michigan, Ann Arbor, shared important data on the relationship between time-dependent cumulative glucocorticoid exposure and major adverse cardiovascular events (MACE) in a cohort of veterans with rheumatoid arthritis (RA).

Filed under:ACR ConvergenceConditionsMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2023Lupus nephritisRA Resource Center

Non-Radiographic Axial Spondyloarthritis: A Review

Jason Liebowitz, MD, FACR  |  November 16, 2023

SAN DIEGO—Alexis Ogdie-Beatty, MD, MSCE, associate professor of medicine, associate professor of epidemiology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, gave a presentation on non-radiographic axial spondyloarthritis (nr-axSpA) in the Review Course prior to ACR Convergence 2023.

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting Reports Tagged with:ACR Convergence 2023AS Resource Center

Cannabis for Pain Relief: An Area Ripe for Research

Vanessa Caceres  |  September 28, 2023

Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:marijuanaPain Syndrome FocusRheum

2024 Proposed Rule for the Quality Payment Program Released

RISE Registry Team  |  August 17, 2023

See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

Filed under:Practice ManagementQuality Assurance/Improvement Tagged with:Medicare Physician Fee Schedule (MPFS)MIPSphysician quality reportingQuality Payment Program (QPP)

  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 32
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences